...
首页> 外文期刊>Advances in Experimental Medicine and Biology >Synthesis Of Organometallic Glycopeptides And Electrochemical Studies To Detect Autoantibodies In Multiple Sclerosis Patients' Sera.
【24h】

Synthesis Of Organometallic Glycopeptides And Electrochemical Studies To Detect Autoantibodies In Multiple Sclerosis Patients' Sera.

机译:有机金属糖肽的合成和检测多发性硬化症患者血清中自身抗体的电化学研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Measurement of disease specific biomarkers, such as antibodies, is an important tool for diagnosis, follow-up, and prevention of autoimmune diseases. Identification of autoantibodies is achieved up to now using native protein antigens in immunoenzymatic assays. Unfortunately, in autoimmune diseases only very low specific antibodies are detected in serum, possibly because protein antigens used in the assays contain more than one epitope, of which only few are involved in the disease. Moreover, the use of recombinant protein antigens doesn't allow reproduction of aberrant post-translational modifications (PTMs) involved in triggering autoantibodies. These observations prompted us to set up an innovative "chemical reverse approach" to select specific synthetic peptide antigens containing the minimal epitope with the correct PTM to fishing out specific biomarkers in biological fluids [1].
机译:疾病特异性生物标记物(例如抗体)的测量是诊断,随访和预防自身免疫性疾病的重要工具。迄今为止,在免疫酶分析中使用天然蛋白抗原可以实现自身抗体的鉴定。不幸的是,在自身免疫性疾病中,在血清中仅检测到非常低的特异性抗体,这可能是因为在测定中使用的蛋白质抗原包含一个以上的表位,其中只有少数表位与该疾病有关。此外,重组蛋白抗原的使用不允许复制触发自身抗体的异常翻译后修饰(PTM)。这些发现促使我们建立了一种创新的“化学逆向方法”,以选择具有最小表位且具有正确PTM的特定合成肽抗原,从而在生物体液中寻找特定的生物标志物[1]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号